High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

Phase 3 Withdrawn Hackensack Meridian Health National Cancer Institute (NCI) · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized phase III trial is studying high dose interferon alfa to see how well it works compared to observation only in treating patients with stage II or stage III melanoma that has been completely removed by surgery.

Timeline

Start: 2000-01
Primary completion: —
Completion: —

Publications

Slawek-Szmyt S, Araszkiewicz A, Jankiewicz S, Grygier M, Mularek-Kubzdela T, Lesiak M. Outcomes With Hybrid Catheter-Directed Therapy Compared With Aspiration Thrombectomy for Patients With Intermediate-High Risk Pulmonary Embolism. Cardiovasc Drugs Ther. 2025 Oct;39(5):1201-1213. doi: 10.1007/s10557-024-07562-4. Epub 2024 Apr 2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	interferon alfa-2b	Protein / enzyme biologic	—	—

High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

Summary

Timeline

Publications

Drugs

Indications